Drugs / native collagen type 2
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT02237989 | Jan → Dec 2013 | osteoarthritis, knee | Eskisehir Osmangazi University | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | native collagen type 2 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02237989 ↗ |
| Known as | native type II collagen | “the other treated with 1500 mg/day of acetaminophen plus 10 mg/day of native type II collagen (group AC+CII; n=20)” PMID 27551171 ↗ Jun 2016 |
| Route | Oral | “oral native type II collagen treatment” PMID 27551171 ↗ Jun 2016 |